Vanguard Group’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.8M | Buy |
|
|||||
|
2025
Q2 | $15.3M | Buy |
|
|||||
|
2025
Q1 | $14.7M | Buy |
|
|||||
|
2024
Q4 | $11.8M | Buy |
|
|||||
|
2024
Q3 | $6.94M | Buy |
|
|||||
|
2024
Q2 | $7.32M | Buy |
|
|||||
|
2024
Q1 | $6.45M | Buy |
|
|||||
|
2023
Q4 | $4.26M | Buy |
|
|||||
|
2023
Q3 | $3.76M | Buy |
|
|||||
|
2023
Q2 | $1.7M | Buy |
|
|||||
|
2023
Q1 | $1.38M | Buy |
|
|||||
|
2022
Q4 | $408K | Buy |
|
|||||
|
2022
Q3 | $1.03M | Hold |
|
|||||
|
2022
Q2 | $1.35M | Sell |
|
|||||
|
2022
Q1 | $2.55M | Sell |
|
|||||
|
2021
Q4 | $3.13M | Buy |
|
|||||
|
2021
Q3 | $4.66M | Buy |
|
|||||
|
2021
Q2 | $6.95M | Buy |
|